PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KraneShares MSCI All China Health Care Index ETF (...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US5007678353

CUSIP

500767835

Issuer

CICC

Inception Date

Feb 1, 2018

Region

Emerging Asia Pacific (China)

Leveraged

1x

Index Tracked

MSCI China All Shares Health Care 10/40 Index

Asset Class

Equity

Asset Class Size

Large-Cap

Asset Class Style

Blend

Expense Ratio

KURE features an expense ratio of 0.65%, falling within the medium range.


Expense ratio chart for KURE: current value at 0.65% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.65%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
KURE vs. CHIQ KURE vs. CNYA KURE vs. CQQQ KURE vs. VOO KURE vs. IYH
Popular comparisons:
KURE vs. CHIQ KURE vs. CNYA KURE vs. CQQQ KURE vs. VOO KURE vs. IYH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in KraneShares MSCI All China Health Care Index ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
-33.09%
108.09%
KURE (KraneShares MSCI All China Health Care Index ETF)
Benchmark (^GSPC)

Returns By Period

KraneShares MSCI All China Health Care Index ETF had a return of -18.20% year-to-date (YTD) and -16.73% in the last 12 months.


KURE

YTD

-18.20%

1M

-2.94%

6M

2.23%

1Y

-16.73%

5Y*

-6.32%

10Y*

N/A

^GSPC (Benchmark)

YTD

23.11%

1M

-0.36%

6M

7.02%

1Y

23.15%

5Y*

12.80%

10Y*

11.01%

Monthly Returns

The table below presents the monthly returns of KURE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-19.04%10.02%-6.73%1.05%-3.22%-6.90%3.02%0.62%21.85%-9.99%1.67%-18.20%
20238.56%-7.15%-4.82%2.24%-9.44%-5.14%6.13%-8.27%1.23%3.19%1.57%-5.43%-17.70%
2022-13.62%0.77%-6.77%-12.28%-0.29%14.78%-8.55%-4.21%-13.48%0.51%17.01%2.69%-25.43%
20215.61%-2.64%-3.04%9.48%3.85%2.94%-12.71%-9.88%4.32%-5.00%-1.83%-5.94%-16.01%
2020-2.20%11.94%-6.01%9.34%3.97%17.86%11.86%0.59%-6.39%3.79%-3.01%15.60%68.98%
20198.32%12.87%5.03%-0.27%-10.96%3.86%1.66%4.82%-3.32%11.17%-5.73%5.02%34.30%
2018-1.21%11.63%-1.98%12.61%-10.27%-6.59%-5.51%-4.91%-12.62%5.71%-17.41%-30.07%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of KURE is 5, meaning it’s performing worse than 95% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of KURE is 55
Overall Rank
The Sharpe Ratio Rank of KURE is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of KURE is 55
Sortino Ratio Rank
The Omega Ratio Rank of KURE is 44
Omega Ratio Rank
The Calmar Ratio Rank of KURE is 44
Calmar Ratio Rank
The Martin Ratio Rank of KURE is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for KraneShares MSCI All China Health Care Index ETF (KURE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for KURE, currently valued at -0.47, compared to the broader market0.002.004.00-0.471.90
The chart of Sortino ratio for KURE, currently valued at -0.50, compared to the broader market-2.000.002.004.006.008.0010.00-0.502.54
The chart of Omega ratio for KURE, currently valued at 0.94, compared to the broader market0.501.001.502.002.503.000.941.35
The chart of Calmar ratio for KURE, currently valued at -0.24, compared to the broader market0.005.0010.0015.00-0.242.81
The chart of Martin ratio for KURE, currently valued at -0.86, compared to the broader market0.0020.0040.0060.0080.00100.00-0.8612.39
KURE
^GSPC

The current KraneShares MSCI All China Health Care Index ETF Sharpe ratio is -0.47. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of KraneShares MSCI All China Health Care Index ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.47
1.90
KURE (KraneShares MSCI All China Health Care Index ETF)
Benchmark (^GSPC)

Dividends

Dividend History

KraneShares MSCI All China Health Care Index ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%5.00%10.00%15.00%$0.00$1.00$2.00$3.00$4.00201820192020202120222023
Dividends
Dividend Yield
PeriodTTM202320222021202020192018
Dividend$0.00$0.11$0.01$4.05$0.00$0.06$0.04

Dividend yield

0.00%0.65%0.05%14.12%0.00%0.25%0.21%

Monthly Dividends

The table displays the monthly dividend distributions for KraneShares MSCI All China Health Care Index ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.11$0.11
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01$0.01
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.05$4.05
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.06$0.06
2018$0.04$0.04

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-65.29%
-3.58%
KURE (KraneShares MSCI All China Health Care Index ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the KraneShares MSCI All China Health Care Index ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the KraneShares MSCI All China Health Care Index ETF was 68.53%, occurring on Jul 8, 2024. The portfolio has not yet recovered.

The current KraneShares MSCI All China Health Care Index ETF drawdown is 65.29%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.53%Feb 18, 2021851Jul 8, 2024
-45.89%Jun 7, 2018145Jan 3, 2019367Jun 19, 2020512
-12.27%Aug 6, 202025Sep 10, 202069Dec 17, 202094
-8.47%Apr 11, 20189Apr 23, 201813May 10, 201822
-7.99%Jan 26, 20214Jan 29, 20217Feb 9, 202111

Volatility

Volatility Chart

The current KraneShares MSCI All China Health Care Index ETF volatility is 11.51%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
11.51%
3.64%
KURE (KraneShares MSCI All China Health Care Index ETF)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab